Carlo Rizzuto 4
4 · Century Therapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Carlo Rizzuto
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-09+19,872→ 19,872 totalExercise: $8.56Exp: 2032-06-09→ Common Stock (19,872 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of (a) June 9, 2023, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.